Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path…
New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer’s disease Cognitive outcomes observed in the…
Trial met primary long episode endpoints with high statistical significance, and RAP-219 was generally well toleratedPatients achieved 77.8% reduction in…
Oversubscribed £50m Series B led by SV Health Investors’ Dementia Discovery Fund, alongside other new investors British Business Bank, M…
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The…
Flexible carbon nanotube-based electrodes achieve high conductivity in brain connections with minimum tissue damage SEOUL, South Korea, Sept. 3, 2025…
New COO, CCO, and CIO Bring Proven Operational, Commercial, and Digital Expertise to Enhance Allucent's Biopharma Partnerships Across Its Expanding…
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media…
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related dataEnhancing dementia research by integrating…
HARTFORD, Conn. & PITTSBURGH--(BUSINESS WIRE)--Abridge’s AI-powered ambient clinical intelligence platform has been selected by Hartford HealthCare, Connecticut’s most comprehensive healthcare…